SCN9A and sodium channelopathy-related small fiber neuropathy: In contrast, gain-of-function mutations in SCN9A result in hyperexcitability of nociceptors and cause debilitating pain disorders such as primary erythromelalgia and paroxysmal extreme pain disorder8, 9.